Roche Acquires Genentech Oncology Partner Piramed
$175 million deal nets Roche a novel program of signal transduction inhibitors with utility in cancer and inflammatory disease.
$175 million deal nets Roche a novel program of signal transduction inhibitors with utility in cancer and inflammatory disease.